Haleon PLC closed 6.80% below its 52-week high of £4.18, which the company reached on March 4th.

Haleon's dividend grew 10% and is well-covered by FCF, but the 1.6% yield is less attractive compared to peers. See why I ...

We recently published a list of 10 Stocks Lead Monday’s Charge Amid Market Bloodbath. In this article, we are going to take a ...

Haleon Pakistan Limited has announced its first international shipment of locally manufactured Centrum multivitamins to Kenya ...

Hsbc Global Res lowered shares of Haleon (NYSE:HLN – Free Report) from a strong-buy rating to a hold rating in a research ...

Shares of Haleon PLC HLN slid 3.40% to £4.01 Wednesday, on what proved to be an all-around dismal trading session for the ...

Haleon is a pure-play consumer healthcare company focusing on oral health, respiratory health, pain relief, vitamins, supplements, and digestive health across 170 markets. Its products include ...

British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half of the year, overshadowing a strong end to 2024 and sending its shares ...

Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company reports full-year results ...

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...

Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion.